John C. Jacobs is recorded as Board Member at Novavax Inc (NVAX) since July 11, 2023 and CEO at Novavax Inc (NVAX). Earlier roles on record: CEO at Harmony Biosciences Holdings, Inc. (HRMY) until January 20, 2023. Novavax Inc reported in an 8-K filed July 11, 2023 that John C. Jacobs was appointed Class I director, effective July 11, 2023. Novavax Inc reported in an 8-K filed January 9, 2023 that John C. Jacobs was appointed member of the Board, effective January 23, 2023. Novavax Inc reported in an 8-K filed January 9, 2023 that John C. Jacobs was appointed President and Chief Executive Officer, effective January 23, 2023. Equibles holds 5 filed executive changes naming John C. Jacobs; each is listed under recent activity with its source filing. The proxy statement of Novavax Inc reports total compensation of $8,856,015 for John C. Jacobs in fiscal 2025, including a base salary of $792,917. Disclosed compensation is on record for 7 fiscal years. John C. Jacobs has spoken on 2 investor events across 1 company, most recently for Novavax Inc on September 10, 2026. Novavax Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Novavax Inc includes Gregory F. Covino (CFO), James P. Kelly (CFO), John J. Trizzino (CFO and COO) and 7 others.
“Stockholders elected the following Class I nominees for director, each to serve a three-year term expiring at the 2026 Annual Meeting of Stockholders: John C. Jacobs”
“On January 5, 2023, the Board of Directors (the “Board”) of Novavax, Inc. (the “Company”) approved the appointment of John C. Jacobs, age 56, as President and Chief Executive Officer and a member of the Board, effective as of January 23, 2023.”
Novavax Inc Form 8-K, filed January 9, 2023
· Read the filing
John C. Jacobs on recent calls
“Appreciate the question, and welcome, everybody. Over the last three and a half years, we've absolutely transformed Novavax.”
“Right now, we couldn't be more excited about where we are in Novavax's history. And as you know, we launched our new strategy in January of 2025. And you asked, Nabil, about proof points.”
